The FDA's Peptide Crackdown: A Complete Timeline
Timeline of FDA enforcement actions against peptide vendors from 2023-2026: warning letters, criminal cases, and regulatory changes.
Independent Peptide Analysis
Evidence-based analysis, vendor accountability, and honest guidance in a market flooded with marketing claims. No vendor sponsorship. No pay-for-play reviews.
Complete timeline of FDA and ITC enforcement actions against peptide vendors from 2024-2026. Warning letters, exclusion orders, and the BPC-157 ban.
New to peptides? Our beginner's guide covers what peptides are, how to evaluate vendors, safety considerations, and what to know first.
Independent deep dive into Infiniwell's SNAC-enhanced BPC-157 products. We examine the technology claims, the missing studies, and what consumers should know.
Learn which peptides have genuine oral bioavailability and which don't. Science-based guide to absorption technologies like SNAC and liposomes.
Analysis of Pentadeca Arginate (PDA) claims: the patent, the chemistry, and the missing evidence behind '99% bioavailability' marketing.
Oral BPC-157 vendors rated on transparency, third-party testing, value, and regulatory compliance. Updated quarterly.
Ratings reflect our independent analysis. Vendors cannot pay to improve their scores. See our methodology.
Evidence-rated profiles for every major peptide. What the research shows, what it doesn't, and what vendors won't tell you.
Weekly analysis of the peptide market: regulatory changes, vendor evaluations, research updates, and the news that matters. Zero vendor influence.